Science’s success at staving off death from heart disease or cancer has made another diagnosis more likely: Dementia.

Alzheimer’s Research UK renews its flagship Drug Discovery Alliance with significant investment at a pivotal moment for ...

Scientists have identified prematurely aged astrocytes in the brains of Alzheimer’s patients, particularly those with the APOE4 risk gene. Their findings suggest that cellular senescence in these ...

The country is facing a coming wave of dementia for its ageing population, and is investing in research into drugs, ...

Scientists have developed a blood test that could predict Alzheimer's symptoms years in advance using p-tau217 protein levels ...

Science’s success at staving off death from heart disease or cancer has made another diagnosis more likely: Dementia.

Scientists have made a breakthrough in understanding how Alzheimer’s disease develops, and a decades-old drug could be the key to stopping the condition in its tracks. It is well established that ...

While physicians and scientists have long known that Alzheimer's disease involves the buildup of toxic protein fragments in the brain, they have struggled to understand how these harmful fragments are ...

The drug would need to be taken long before symptoms first appear—but it could be used to help protect at-risk individuals.

A new drug for treating Alzheimer’s has only a marginal impact on people with the early stages of the memory loss disease and ...

State Sen. Jason Prokop introduced the measure, which would require insurance companies to cover certain Food and Drug ...